Back to Trades
Lee Sung
InsiderCIK 0001793200
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 7
- Buy transactions
- 0
- Sell transactions
- 1
- Companies
- 2
- Active
- 2025–2026
Lee Sung has filed 7 reports across 2 companies, totaling $3.0M in disclosed volume. Sales ($306.7K) outpace purchases ($0). Insider sales are common for diversification and should be read in context. All data sourced from SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
7 loaded
| Jun 8 | TNGX Tango Therapeutics, Inc. | Lee Sung | Insider | Grant | $0 |
| May 1 | TNGX Tango Therapeutics, Inc. | Lee Sung | Insider | Grant | $0 |
| Mar 18 | CYTK CYTOKINETICS INC | Lee Sung | EVP, Chief Financial Officer | Sell | $306.7K |
| Mar 17 | CYTK CYTOKINETICS INC | Lee Sung | EVP, Chief Financial Officer | Grant | $0 |
| Jan 6 | TNGX Tango Therapeutics, Inc. | Lee Sung | Insider | Grant | $0 |
| Jan 6 | TNGX Tango Therapeutics, Inc. | Lee Sung | Insider | Other | $0 |
| Dec 29 | CYTK CYTOKINETICS INC | Lee Sung | EVP, Chief Financial Officer | Grant | $0 |
7 filings